Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1445319Generated: November 2, 2026

Cholesterol → HCID 86607619, compound

https://huagongshe.com/reaction/1445319

Reaction equation

Participants

RoleNameHCIDCharge
ReactantCholesterolHCID 5997—
ReactantHCID 18664939HCID 18664939—
CatalystSilver(I) trifluoromethanesulfonateHCID 76223—
SolventDichloromethaneHCID 6344—
ProductHCID 86607619HCID 86607619—

Reaction Steps

Compound 4 (see FIG. 12) was prepared from galactose 1 that was treated with pivaloyl chloride in pyridine. Instead of the expected penta-pivaloyl derivative, the partially pivaloylated compound 2 was obtained in good yield and high purity without the need of chromatographic purification. The free hydroxyl group in compound 2 was protected by an acetyl group (→3). This was followed by treatment with hydrogen bromide in acetic acid to provide the galactosyl bromide 4. Bromide 4 was coupled with cholesterol 5 under promotion by silver trifluoromethanesulfonate in dichloromethane to provide the desired β-galactosyl-cholesterol 6 in a stereoselective manner (see FIG. 13). The β-anomeric configuration was demonstrated by 1-H NMR spectroscopy. The O-protecting groups were subsequently removed by treatment with sodium methoxide in a mixture of anhydrous dichloromethane and methanol to provide the cholesteryl β-D-galactopyranoside 7 as an amorphous solid.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS07666846B2
Source datasetuspto-grants-2010_02
ORD IDord-bc06666b6d644ce0bec31279f27044f4
Source noteuspto-grants-2010_02